| Tretinoin | Approved Investigational Nutraceutical | IFI6 | 2537 |
upregulated | Tretinoin results in increased expression of IFI6 mRNA | 1p35.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IFIT1 | 3434 |
downregulated | Tretinoin results in decreased expression of IFIT1 mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IFIT1 | 3434 |
upregulated | Tretinoin results in increased expression of IFIT1 mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IFIT2 | 3433 |
downregulated | Tretinoin results in decreased expression of IFIT2 mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IFIT2 | 3433 |
upregulated | Tretinoin results in increased expression of IFIT2 mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IFIT3 | 3437 |
upregulated | Tretinoin results in increased expression of IFIT3 mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IFITM1 | 8519 |
upregulated | Tretinoin results in increased expression of IFITM1 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | IFITM3 | 10410 |
upregulated | Tretinoin results in increased expression of IFITM3 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | IFNG | 3458 |
downregulated | Tretinoin results in decreased expression of IFNG mRNA | 12q15 | |
| Tretinoin | Approved Investigational Nutraceutical | IFRD2 | 7866 |
downregulated | Tretinoin results in decreased expression of IFRD2 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IFT57 | 55081 |
downregulated | Tretinoin results in decreased expression of IFT57 mRNA | 3q13.12-q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | IFT88 | 8100 |
upregulated | Tretinoin results in increased expression of IFT88 mRNA | 13q12.11 | |
| Tretinoin | Approved Investigational Nutraceutical | IGDCC3 | 9543 |
upregulated | Tretinoin results in increased expression of IGDCC3 mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IGDCC4 | 57722 |
downregulated | Tretinoin results in decreased expression of IGDCC4 mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | IGF1 | 3479 |
upregulated | Tretinoin metabolite results in increased expression of IGF1 mRNA | 12q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | IGF1 | 3479 |
upregulated | Tretinoin results in increased expression of IGF1 mRNA | 12q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | IGF2 | 3481 |
upregulated | Tretinoin metabolite results in increased expression of IGF2 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | IGF2 | 3481 |
downregulated | Tretinoin results in decreased expression of IGF2 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | IGFBP2 | 3485 |
downregulated | Tretinoin results in decreased expression of IGFBP2 mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | IGFBP3 | 3486 |
upregulated | Tretinoin results in increased expression of IGFBP3 mRNA | 7p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IGFBP4 | 3487 |
downregulated | Tretinoin results in decreased expression of IGFBP4 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | IGFBP5 | 3488 |
downregulated | Tretinoin results in decreased expression of IGFBP5 mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | IGFBP6 | 3489 |
downregulated | Tretinoin results in decreased expression of IGFBP6 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | IGFBP6 | 3489 |
upregulated | Tretinoin results in increased expression of IGFBP6 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | IGFBP7 | 3490 |
downregulated | Tretinoin results in decreased expression of IGFBP7 mRNA | 4q12 | |